ebomi
Colour theme
Sign in
Insider · CIK 0001352546

Flynn James E

CIK 0001352546 Name as filed on the most recent filing

Filed as Flynn James E (269)

1,449 transaction lines · from 269 filings · filed 2006-02-08 to 2026-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

10 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-06-12 S, Open-market sale Antares Pharma, Inc.ATRS 44,986, disposed Open Form 4 filing 0001193805-15-000970
2015-06-12 S, Open-market sale Antares Pharma, Inc.ATRS 19,007, disposed Open Form 4 filing 0001193805-15-000970
2015-06-12 S, Open-market sale Antares Pharma, Inc.ATRS 19,007, disposed Open Form 4 filing 0001193805-15-000970
2015-06-11 S, Open-market sale Antares Pharma, Inc.ATRS 6 lines 838,832, disposed Open Form 4 filing 0001193805-15-000970
2015-05-12 P, Open-market purchase aTYR Pharma IncLIFE 2 lines 700,000, acquired Open Form 4 filing 0001193805-15-000724
2015-04-08 S, Open-market sale AxoGen, Inc.AXGN 469,251, disposed Open Form 4 filing 0001193805-15-000544
2015-03-25 P, Open-market purchase SteadyMed Ltd.STDY 2 lines 6,269,218, acquired Open Form 4 filing 0001193805-15-000427
2015-03-06 P, Open-market purchase eHealth, Inc.EHTH 2 lines 286,581, acquired Open Form 4 filing 0001193805-15-000347
2015-02-18 P, Open-market purchase Invitae CorpNVTA 3 lines 2,800,000, acquired Open Form 4 filing 0001193805-15-000295
2015-01-28 P, Open-market purchase Auspex Pharmaceuticals, Inc.ASPX 5 lines 84,750,000, acquired Open Form 4 filing 0001193805-15-000056
2015-01-14 P, Open-market purchase eHealth, Inc.EHTH 4 lines 20,302,400, acquired Open Form 4 filing 0001193805-15-000039
2015-01-01 S, Open-market sale CAS Medical Systems IncCASM 2,381,280, disposed Open Form 4 filing 0001193805-15-000002
2015-01-01 P, Open-market purchase CAS Medical Systems IncCASM 2,381,280, acquired Open Form 4 filing 0001193805-15-000002
2014-12-23 P, Open-market purchase Vanda Pharmaceuticals Inc.VNDA 12 lines 2,332,713, acquired Open Form 4 filing 0001193805-14-002712
2014-11-25 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 3 lines 1,402,598, disposed Open Form 4 filing 0001193805-14-002286
2014-11-24 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 477,465, disposed Open Form 4 filing 0001193805-14-002286
2014-11-24 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 416,655, disposed Open Form 4 filing 0001193805-14-002286
2014-11-24 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 163,998, disposed Open Form 4 filing 0001193805-14-002286
2014-11-24 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 43,679, disposed Open Form 4 filing 0001193805-14-002286
2014-11-24 S, Open-market sale Dicerna Pharmaceuticals IncDRNA 38,117, disposed Open Form 4 filing 0001193805-14-002286

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Flynn James E, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001352546

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.